FDA Inspection 1280792 — Ritsa Pharma Private Limited

Ritsa Pharma Private Limited — FEI 3025926685

The FDA completed an inspection of Ritsa Pharma Private Limited on September 5, 2025 in Medchal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 5, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Medchal (India)

Citations

IDCFRDescription
184421 CFR 211.84(d)(2)Establish reliability of supplier's C of A